NASDAQ: CLRB
Cellectar Biosciences Inc Stock Ownership - Who owns Cellectar Biosciences?

Insider buying vs selling

Have Cellectar Biosciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jarrod LongcorChief Operating Officer2025-01-1030,000$0.28
$8.40kBuy

1 of 1

CLRB insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CLRB insiders and whales buy or sell their stock.

CLRB Shareholders

What type of owners hold Cellectar Biosciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Vanguard Group Inc3.74%1,721,838$711.12kInstitution
Austin W. Greenhouse David M. Marxe2.48%1,142,368$471.80kInsider
John Neis2.15%989,818$408.79kInsider
Ubs Group Ag2.00%920,352$380.11kInstitution
Cormorant Asset Management LP1.15%530,000$218.89kInsider
Alumni Research Foundation Wisconsin1.02%469,484$193.90kInsider
Geode Capital Management LLC0.96%443,424$183.13kInstitution
Squarepoint Ops LLC0.80%370,865$153.17kInstitution
Citadel Advisors LLC0.74%343,258$141.77kInstitution
Richard Hertzberg0.61%280,000$115.64kInsider

1 of 3

CLRB vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CLRB11.30%8.96%Net Buying
NXTC52.31%47.69%
CARM13.34%73.98%
LGVN3.12%96.88%Net SellingNet Selling
CGTX18.76%41.06%Net SellingNet Selling

Cellectar Biosciences Stock Ownership FAQ

Who owns Cellectar Biosciences?

Cellectar Biosciences (NASDAQ: CLRB) is owned by 11.30% institutional shareholders, 8.96% Cellectar Biosciences insiders, and 79.74% retail investors. Austin W. Greenhouse David M. Marxe is the largest individual Cellectar Biosciences shareholder, owning 1.14M shares representing 2.48% of the company. Austin W. Greenhouse David M. Marxe's Cellectar Biosciences shares are currently valued at $471.80k.

If you're new to stock investing, here's how to buy Cellectar Biosciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.